MGTA - Magenta Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $18.54. This is a potential upside of $5.32 (40.24%) from yesterday's end of day stock price of $13.22.

Magenta Therapeutics's activity chart (see below) currently has 13 price targets and 18 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 51.67% with an average time for these price targets to be met of 176.9 days.

Most recent stock forecast was given by YUN ZHONG from BTIG on 26-Jan-2023. First documented stock forecast 25-Mar-2019.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 15-Jun-2021

3 years 2 months 9 days ago
(26-Jan-2023)

1/2 (50%)

$-3.28 (-52.23%)

329

Hold Since 26-Jan-2023

$3

$-8.19 (-73.19%)

3 years 2 months 9 days ago
(26-Jan-2023)

1/2 (50%)

$-4.04 (-57.39%)

406

Buy Since 08-Mar-2022

$2

3 years 7 months 10 days ago
(25-Aug-2022)

1/2 (50%)

$-16.72 (-89.32%)

287

Buy Since 07-Jan-2021

$128

$116.81 (1043.88%)

3 years 11 months 17 days ago
(18-Apr-2022)

0/2 (0%)

$97.28 (316.67%)

Buy Since 01-Dec-2021

$128

$116.81 (1043.88%)

$272

3 years 11 months 17 days ago
(18-Apr-2022)

0/3 (0%)

$97.28 (316.67%)

Show more analysts

Please expand the browser size to see the chart

What is MGTA (Magenta Therapeutics) average time for price targets to be met?

On average it took 176.9 days on average for the stock forecasts to be realized with a an average price target met ratio 51.67

Which analyst has the current highest performing score on MGTA (Magenta Therapeutics) with a proven track record?

KALPIT PATEL

Which analyst has the most public recommendations on MGTA (Magenta Therapeutics)?

Kalpit Patel works at B. RILEY and has 6 price targets and 5 ratings on MGTA

Which analyst is the currently most bullish on MGTA (Magenta Therapeutics)?

Vamil Divan with highest potential upside - $116.81

Which analyst is the currently most reserved on MGTA (Magenta Therapeutics)?

David Nierengarten with lowest potential downside - -$8.19

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?